Oct 13 (Reuters) - WCG Clinical Inc, a clinical trial solutions company backed by Singapore's sovereign wealth fund GIC, on Wednesday filed to withdraw its initial public offering in the United States. (Reporting by Niket Nishant in Bengaluru; Editing by Shailesh Kuber)
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | -.--% | -.--% |
2021 | WCG Clinical : GIC-backed clinical trial firm WCG withdraws U.S. IPO plans | RE |
2021 | WCG Clinical : GIC-backed clinical trial firm WCG withdraws IPO plans | RE |
1st Jan change | Capi. | |
---|---|---|
-.--% | 6.07B | |
+17.96% | 44.96B | |
+48.77% | 41.85B | |
+1.17% | 42.65B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- WCGC Stock
- News WCG Clinical, Inc.
- WCG Clinical : GIC-backed clinical trial firm WCG withdraws IPO plans